Sun Pharma replaces domestic formulations distributor with its own subsidiary

Last week, Sun Pharmaceutical asked markets regulator Sebi to look into the issues of certain entities and individuals allegedly adopting unfair trade practices prejudicial to the company's shareholders.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2WbK9R4
via IFTTT